Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: report of two cases
Gil Cunha De Santis, Leandro Dorigan de Macedo, Maristela Delgado Orellana, Lara Maria Alencar Ramos Innocentini, Tatiane Cristina Ferrari, Hilton Marcos Alves Ricz, Sâmia Rigotto Caruso, Taísa Risque Fernandes, Dimas Tadeu Covas
Abstract
Biphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) was first reported in 2003 [1] and affects approximately 5% of patients with multiple myeloma (MM), breast or prostate metastatic cancer ...
Topics & Concepts
MedicineOsteonecrosis of the jawMesenchymal stem cellMultiple myelomaBisphosphonateStromal cellProstate cancerBreast cancerOncologyPathologyCancerDentistryInternal medicineOsteoporosisBone health and treatmentsBone and Joint DiseasesCancer Diagnosis and Treatment